DSCSAInsightsForDispenser_PharmacyTimes
  • Healthcare

    • Understanding DSCSA: Insights for All Dispensers

    The article discusses how the DSCSA impacts medication dispensers, emphasizing compliance to protect patient safety and maintain supply chain integrity. It covers pharmaceutical crime, counterfeit drug risks, key DSCSA measures like product serialization, and stresses technology's role in ensuring authenticity. Compliance with regulations is crucial for a secure healthcare environment.
    Chain Drug Review_DIR Reform_Blog_Thought Leadership Graphic
  • Healthcare

    • DIR reform in 2024: One step forward, two steps back

    The article delves into the advancements and obstacles facing Direct and Indirect Remuneration (DIR) reform in 2024 within the pharmacy sector. It outlines the move from retroactive to upfront DIR fees, the financial pressures on pharmacies, and initiatives to broaden the scope of pharmacy services. Despite certain improvements like clawback elimination, the transition has introduced cash flow difficulties and decreased transparency. The article underscores the significance of comprehending and managing these reforms to bolster pharmacy viability and promote value-based care endeavors.

    US Department of Health and Human Services Selects Inmar Intelligence for a 5-year Contract to Deliver Pharmaceutical Supply Chain Solutions

    Inmar Intelligence, a leading provider of data-driven healthcare technology solutions, today announced it has secured a contract with the US Department of Health and Human Services (HHS) to provide pharmaceutical supply chain solutions across the country.
    HealthcarePricingRapidResponseBlog
  • Healthcare

    • The Push for Healthcare Price Transparency: Will Pharmacies See a Benefit?

    By Jason Murry, Senior Director, Healthcare Sales: Recent passage of the Lower Costs, More Transparency (LCMT) Act in a bipartisan vote by the U.S. House of Representatives is being heralded by the bill’s sponsors as “landmark legislation,” but is it really? The bill -- which is a long way from becoming law -- is focused on the very politically popular issue of lowering prescription drug prices for consumers. But where is the benefit for pharmacies?  

    Drug Stewardship Program from Inmar Gains Preliminary Approval from the Illinois Environmental Protection Agency

    Inmar Intelligence, an experienced drug stewardship operator and leader in pharmaceutical reverse distribution, is pleased to announce that the Illinois Environmental Protection Agency (IEPA) granted preliminary approval of its Drug Stewardship program for the State of Illinois on September 26.
    Subscribe to